After the disclosure from AstraZeneca that it’s under Justice Department scrutiny for illegally funding Iraqi terrorism, Roche and Johnson & Johnson revealed similar inquiries from the agency.
The extended deal with DSM offers Aerie an elite worldwide license to DSM’s polyesteramide polymer technology for a limitless number of drugs in any ophthalmic indication and also an exposure to DSM’s preclinical latanoprost implant created for people with glaucoma. The two companies have spanned their partnership till the end of 2020, as per Aerie.
Kindbody, a women-empowered startup was launched on Tuesday by Gina Bartasi, Progyny founder and other women leaders, remarkably co-founders Fahimeh Sasan, MD, from Mount Sinai, and Joanne Schneider, former product leader at Google and Flatiron Health, and Cynthia Hudson, clinical embryology and IVF expert and owner of Manhattan Fertility Specialists.
Wall Street is unclear whether the U.S. insurance industry will have to pay any costs from the $4.69 billion verdict against Johnson & Johnson granted to customers and their families who alleged that asbestos-adulterated talc leads to ovarian cancer.
New sponsor OCA Ventures along with existing financiers have granted $1 million in Series A funding to PatientWisdom, a digital health corporation working on real-world data compilation tools. The company’s total funding is now worth $3.45 million.
Last year, around 100 veterans filed a bombshell lawsuit against several drugmakers, by accusing that they funded terrorism by paying high bribes to win contracts with the Iraqi Ministry of Health. At present, the Department of Justice is investigating similar accusations, as per AstraZeneca securities filing which says that it's part of the probe.
Wal-Mart had decided to leave the partnership with Castlight Health at the end of its current contract instead of transferring over to Castlight Complete, the company's new platform which was designed to bring the care navigation tools out to customers.
The German drugmaker Bayer has approved to sell its well-known prescription dermatology brands to Denmark’s Leo Pharma, as it focuses on integrating Monsanto also for strengthening its drug development pipeline.
Clinical Innovations has launched its new subsidiary in Shanghai to grow in the Chinese labor and delivery market, expanding its global footprint.
HiFiBiO Therapeutics is aspiring to work on antibody therapies for different gastrointestinal diseases, cancers and other disorders by signing a pact with Japanese Pharma and biotech company Takeda.
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.